Literature DB >> 23268368

The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium.

Silke Frey1, Anja Derer, Maria-Elena Messbacher, Dominique L P Baeten, Serena Bugatti, Carlomaurizio Montecucco, Georg Schett, Axel J Hueber.   

Abstract

BACKGROUND: Interleukin (IL)-36α is a recently described member of the IL-1 cytokine family with pro-inflammatory and clearly pathogenic properties in psoriasis.
OBJECTIVE: To determine the IL-36α expression in psoriatic arthritis (PsA) compared to rheumatoid arthritis (RA) and osteoarthritis (OA).
METHODS: Synovial tissues obtained from arthritis patients were stained for IL-36α, IL-36 receptor (IL-36R) and IL-36R antagonist (IL-36Ra) by immunohistochemistry and immunofluorescence. Lysates were examined for IL-36α by western blot analysis. Synovial fibroblasts (FLS) cultured in the presence of IL-36α were assayed for cytokine expression by quantitative real time PCR and multiplex assay. IL-36α-induced signal transduction in FLS was analysed by immunoblotting.
RESULTS: Expression of IL-36R and its ligands IL-36α and IL-36Ra was detected in the synovial lining layer and cellular infiltrates of patients with inflammatory arthritis. IL-36α was expressed significantly higher in PsA and RA than in OA synovium. CD138-positive plasma cells were identified as the main cellular source of IL-36α. No differences were observed for the expression of IL-36R and IL-36Ra between PsA, RA and OA. Functionally, IL-36α induced the expression of IL-6 and IL-8 in FLS through p38/NFkB activation.
CONCLUSIONS: IL-36α is up-regulated in PsA and RA synovium, expressed by tissue plasma cells and leads to IL-6 and IL-8 production by synovial fibroblasts. Hence, IL-36α links plasma cells to inflammatory cytokine production by FLS and may represent a key link between autoimmunity and the induction of synovitis.

Entities:  

Keywords:  Arthritis; Cytokines; Inflammation

Mesh:

Substances:

Year:  2012        PMID: 23268368     DOI: 10.1136/annrheumdis-2012-202264

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  61 in total

1.  [New aspects on the pathogenesis of psoriatic arthritis].

Authors:  A J Hueber; B Manger
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

2.  Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.

Authors:  F Ciccia; A Accardo-Palumbo; R Alessandro; C Alessandri; R Priori; G Guggino; S Raimondo; F Carubbi; G Valesini; R Giacomelli; A Rizzo; G Triolo
Journal:  Clin Exp Immunol       Date:  2015-06-03       Impact factor: 4.330

Review 3.  Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight.

Authors:  Cuong Thach Nguyen; Yehudi Bloch; Katarzyna Składanowska; Savvas N Savvides; Iannis E Adamopoulos
Journal:  Clin Immunol       Date:  2018-09-06       Impact factor: 3.969

4.  Inflammation: IL-36 has proinflammatory effects in skin but not in joints.

Authors:  Damien Dietrich; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

5.  Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease.

Authors:  Garrett J Patrick; Haiyun Liu; Martin P Alphonse; Dustin A Dikeman; Christine Youn; Jack C Otterson; Yu Wang; Advaitaa Ravipati; Momina Mazhar; George Denny; Roger V Ortines; Emily Zhang; Robert J Miller; Carly A Dillen; Qi Liu; Sabrina J Nolan; Kristine Nguyen; LeeAnn Marcello; Danh C Do; Eric M Wier; Yan Zhang; Gary Caviness; Alexander C Klimowicz; Diane V Mierz; Jay S Fine; Guangping Sun; Raphaela Goldbach-Mansky; Alina I Marusina; Alexander A Merleev; Emanual Maverakis; Luis A Garza; Joshua D Milner; Peisong Gao; Meera Ramanujam; Ernest L Raymond; Nathan K Archer; Lloyd S Miller
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

6.  Serum levels of cytokines in systemic lupus erythematosus : Association study in a Chinese population.

Authors:  M Zhang; W-D Xu; Y Zhu; P-F Wen; R-X Leng; H-F Pan; D-Q Ye
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

7.  IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression.

Authors:  Sol Kim; Drake W Williams; Cindy Lee; Terresa Kim; Atsushi Arai; Songtao Shi; Xinmin Li; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  J Bone Miner Res       Date:  2016-10-12       Impact factor: 6.741

Review 8.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

Review 9.  Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 20.543

10.  Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.

Authors:  M-A Boutet; G Bart; M Penhoat; J Amiaud; B Brulin; C Charrier; F Morel; J-C Lecron; M Rolli-Derkinderen; A Bourreille; S Vigne; C Gabay; G Palmer; B Le Goff; F Blanchard
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.